vs
雅培（ABT）与Enhabit, Inc.（EHAB）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是Enhabit, Inc.的42.4倍（$11.5B vs $270.4M）。雅培净利率更高（15.5% vs -14.3%，领先29.8%）。Enhabit, Inc.同比增速更快（4.7% vs 4.4%）。雅培自由现金流更多（$2.6B vs $3.3M）。过去两年雅培的营收复合增速更高（7.2% vs 1.5%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
Enhabit, Inc.是总部位于美国得克萨斯州达拉斯的居家护理与临终关怀服务提供商，目前在全美34个州运营255个居家护理站点与110个临终关怀站点，业务集中在得克萨斯、亚拉巴马、佛罗里达、佐治亚、俄克拉荷马与密西西比，是美国第四大居家护理服务商，也是头部临终关怀服务商，2022年由恩compass健康拆分居家护理与临终关怀业务拆分成立。
ABT vs EHAB — 直观对比
营收规模更大
ABT
是对方的42.4倍
$270.4M
营收增速更快
EHAB
高出0.3%
4.4%
净利率更高
ABT
高出29.8%
-14.3%
自由现金流更多
ABT
多$2.6B
$3.3M
两年增速更快
ABT
近两年复合增速
1.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $270.4M |
| 净利润 | $1.8B | $-38.7M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | -12.3% |
| 净利率 | 15.5% | -14.3% |
| 营收同比 | 4.4% | 4.7% |
| 净利润同比 | -80.8% | 15.9% |
| 每股收益（稀释后） | $1.01 | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTEHAB
| Q4 25 | $11.5B | $270.4M | ||
| Q3 25 | $11.4B | $263.6M | ||
| Q2 25 | $11.1B | $266.1M | ||
| Q1 25 | $10.4B | $259.9M | ||
| Q4 24 | $11.0B | $258.2M | ||
| Q3 24 | $10.6B | $253.6M | ||
| Q2 24 | $10.4B | $260.6M | ||
| Q1 24 | $10.0B | $262.4M |
净利润ABTEHAB
| Q4 25 | $1.8B | $-38.7M | ||
| Q3 25 | $1.6B | $11.1M | ||
| Q2 25 | $1.8B | $5.2M | ||
| Q1 25 | $1.3B | $17.8M | ||
| Q4 24 | $9.2B | $-46.0M | ||
| Q3 24 | $1.6B | $-110.2M | ||
| Q2 24 | $1.3B | $-200.0K | ||
| Q1 24 | $1.2B | $200.0K |
毛利率ABTEHAB
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
营业利润率ABTEHAB
| Q4 25 | 19.6% | -12.3% | ||
| Q3 25 | 18.1% | 6.4% | ||
| Q2 25 | 18.4% | 6.3% | ||
| Q1 25 | 16.3% | 6.1% | ||
| Q4 24 | 17.4% | -16.0% | ||
| Q3 24 | 17.5% | -38.6% | ||
| Q2 24 | 16.1% | 4.3% | ||
| Q1 24 | 13.9% | 4.9% |
净利率ABTEHAB
| Q4 25 | 15.5% | -14.3% | ||
| Q3 25 | 14.5% | 4.2% | ||
| Q2 25 | 16.0% | 2.0% | ||
| Q1 25 | 12.8% | 6.8% | ||
| Q4 24 | 84.1% | -17.8% | ||
| Q3 24 | 15.5% | -43.5% | ||
| Q2 24 | 12.5% | -0.1% | ||
| Q1 24 | 12.3% | 0.1% |
每股收益（稀释后）ABTEHAB
| Q4 25 | $1.01 | $-0.76 | ||
| Q3 25 | $0.94 | $0.22 | ||
| Q2 25 | $1.01 | $0.10 | ||
| Q1 25 | $0.76 | $0.35 | ||
| Q4 24 | $5.26 | $-0.92 | ||
| Q3 24 | $0.94 | $-2.20 | ||
| Q2 24 | $0.74 | $0.00 | ||
| Q1 24 | $0.70 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $43.6M |
| 总债务越低越好 | $12.9B | $426.0M |
| 股东权益账面价值 | $52.1B | $534.0M |
| 总资产 | $86.7B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.80× |
8季度趋势，按日历期对齐
现金及短期投资ABTEHAB
| Q4 25 | $8.9B | $43.6M | ||
| Q3 25 | $7.7B | $56.9M | ||
| Q2 25 | $7.3B | $37.1M | ||
| Q1 25 | $6.8B | $39.5M | ||
| Q4 24 | $8.0B | $28.4M | ||
| Q3 24 | $7.8B | $45.7M | ||
| Q2 24 | $7.2B | $28.5M | ||
| Q1 24 | $6.7B | $36.5M |
总债务ABTEHAB
| Q4 25 | $12.9B | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | $14.1B | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M | ||
| Q1 24 | — | $526.7M |
股东权益ABTEHAB
| Q4 25 | $52.1B | $534.0M | ||
| Q3 25 | $51.0B | $566.8M | ||
| Q2 25 | $50.6B | $552.4M | ||
| Q1 25 | $48.8B | $543.2M | ||
| Q4 24 | $47.7B | $523.5M | ||
| Q3 24 | $39.8B | $566.1M | ||
| Q2 24 | $39.3B | $674.3M | ||
| Q1 24 | $38.8B | $672.3M |
总资产ABTEHAB
| Q4 25 | $86.7B | $1.2B | ||
| Q3 25 | $84.2B | $1.2B | ||
| Q2 25 | $84.0B | $1.2B | ||
| Q1 25 | $81.4B | $1.2B | ||
| Q4 24 | $81.4B | $1.2B | ||
| Q3 24 | $74.4B | $1.3B | ||
| Q2 24 | $73.0B | $1.4B | ||
| Q1 24 | $72.5B | $1.4B |
负债/权益比ABTEHAB
| Q4 25 | 0.25× | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | 0.30× | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $4.4M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $3.3M |
| 自由现金流率自由现金流/营收 | 22.9% | 1.2% |
| 资本支出强度资本支出/营收 | 6.0% | 0.4% |
| 现金转化率经营现金流/净利润 | 1.87× | — |
| 过去12个月自由现金流最近4个季度 | $7.4B | $65.8M |
8季度趋势，按日历期对齐
经营现金流ABTEHAB
| Q4 25 | $3.3B | $4.4M | ||
| Q3 25 | $2.8B | $37.8M | ||
| Q2 25 | $2.0B | $10.6M | ||
| Q1 25 | $1.4B | $17.9M | ||
| Q4 24 | $2.9B | $-4.1M | ||
| Q3 24 | $2.7B | $28.4M | ||
| Q2 24 | $2.0B | $9.6M | ||
| Q1 24 | $1.0B | $17.3M |
自由现金流ABTEHAB
| Q4 25 | $2.6B | $3.3M | ||
| Q3 25 | $2.3B | $36.2M | ||
| Q2 25 | $1.5B | $8.7M | ||
| Q1 25 | $933.0M | $17.6M | ||
| Q4 24 | $2.1B | $-4.7M | ||
| Q3 24 | $2.1B | $27.7M | ||
| Q2 24 | $1.4B | $8.9M | ||
| Q1 24 | $627.0M | $15.5M |
自由现金流率ABTEHAB
| Q4 25 | 22.9% | 1.2% | ||
| Q3 25 | 20.2% | 13.7% | ||
| Q2 25 | 13.9% | 3.3% | ||
| Q1 25 | 9.0% | 6.8% | ||
| Q4 24 | 19.6% | -1.8% | ||
| Q3 24 | 20.2% | 10.9% | ||
| Q2 24 | 13.8% | 3.4% | ||
| Q1 24 | 6.3% | 5.9% |
资本支出强度ABTEHAB
| Q4 25 | 6.0% | 0.4% | ||
| Q3 25 | 4.4% | 0.6% | ||
| Q2 25 | 4.5% | 0.7% | ||
| Q1 25 | 4.7% | 0.1% | ||
| Q4 24 | 6.6% | 0.2% | ||
| Q3 24 | 5.2% | 0.3% | ||
| Q2 24 | 5.1% | 0.3% | ||
| Q1 24 | 4.0% | 0.7% |
现金转化率ABTEHAB
| Q4 25 | 1.87× | — | ||
| Q3 25 | 1.70× | 3.41× | ||
| Q2 25 | 1.15× | 2.04× | ||
| Q1 25 | 1.07× | 1.01× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 0.84× | 86.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
